Publicaciones en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (31)

2024

  1. Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population

    Journal of Endocrinological Investigation, Vol. 47, Núm. 6, pp. 1405-1418

  2. Coronavirus disease 2019 is associated with long-term depressive symptoms in Spanish older adults with overweight/obesity and metabolic syndrome

    Psychological Medicine, Vol. 54, Núm. 3, pp. 620-630

  3. Mindfulness-based cognitive therapy neurobiology in treatment-resistant obsessive-compulsive disorder: A domain-related resting-state networks approach

    European Neuropsychopharmacology, Vol. 82, pp. 72-81

  4. Sex differences in clinical response to deep brain stimulation in resistant obsessive-compulsive disorder

    Spanish Journal of Psychiatry and Mental Health

2023

  1. Association of adiposity and its changes over time with COVID-19 risk in older adults with overweight/obesity and metabolic syndrome: a longitudinal evaluation in the PREDIMED-Plus cohort

    BMC Medicine, Vol. 21, Núm. 1

  2. Higher versus lower nut consumption and changes in cognitive performance over two years in a population at risk of cognitive decline: a cohort study

    American Journal of Clinical Nutrition, Vol. 118, Núm. 2, pp. 360-368

  3. Intensive Weight-Loss Lifestyle Intervention Using Mediterranean Diet and COVID-19 Risk in Older Adults: Secondary Analysis of PREDIMED-Plus Trial

    Journal of Nutrition, Health and Aging, Vol. 27, Núm. 12, pp. 1162-1167

  4. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study

    European Neuropsychopharmacology, Vol. 67, pp. 53-65

2022

  1. Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia

    Schizophrenia Research, Vol. 243, pp. 32-42

  2. Long-term comparative effectiveness of deep brain stimulation in severe obsessive-compulsive disorder

    Brain Stimulation, Vol. 15, Núm. 5, pp. 1128-1138

  3. Polyphenol intake and cardiovascular risk in the PREDIMED-Plus trial. A comparison of different risk equations

    Revista Espanola de Cardiologia, Vol. 75, Núm. 5, pp. 401-411

  4. Preimplantation genetic testing for a chr14q32 microdeletion in a family with Kagami-Ogata syndrome and Temple syndrome

    Journal of Medical Genetics, Vol. 59, Núm. 3, pp. 253-261

  5. SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas

    Journal of Controlled Release, Vol. 342, pp. 81-92

  6. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study

    European Neuropsychopharmacology, Vol. 57, pp. 105-117

  7. Viability Study of Machine Learning-Based Prediction of COVID-19 Pandemic Impact in Obsessive-Compulsive Disorder Patients

    Frontiers in Neuroinformatics, Vol. 16

2021

  1. Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)

    Critical Care

  2. Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)

    PLoS ONE, Vol. 16, Núm. 9 September

  3. How is COVID-19 affecting patients with obsessive–compulsive disorder? A longitudinal study on the initial phase of the pandemic in a Spanish cohort

    European Psychiatry, Vol. 64, Núm. 1

  4. The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

    Critical Care, Vol. 25, Núm. 1

  5. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252